Additional file 2 of Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial

Kristensen, Anna Meta Dyrvig; Bovin, Ann; Zwisler, Ann Dorthe; Cerquira, Charlotte; Torp-Pedersen, Christian; Bøtker, Hans Erik; Gustafsson, Ida; Veien, Karsten Tange; Thomsen, Kristian Korsgaard; Olsen, Michael Hecht; Larsen, Mogens Lytken; Nielsen, Olav Wendelboe; Hildebrandt, Per; Foghmar, Sussie; Jensen, Svend Eggert; Lange, Theis; Sehested, Thomas; Jernberg, Tomas; Atar, Dan; Ibanez, Borja; Prescott, Eva

doi:10.6084/m9.figshare.12362462.v1

13063_2020_4214_MOESM2_ESM.docx (30.04 kB)

Additional file 2 of Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial

journal contribution

posted on 2020-05-24, 03:55 authored by Anna Meta Dyrvig Kristensen, Ann Bovin, Ann Dorthe Zwisler, Charlotte Cerquira, Christian Torp-Pedersen, Hans Erik Bøtker, Ida Gustafsson, Karsten Tange Veien, Kristian Korsgaard Thomsen, Michael Hecht Olsen, Mogens Lytken Larsen, Olav Wendelboe Nielsen, Per Hildebrandt, Sussie Foghmar, Svend Eggert Jensen, Theis Lange, Thomas Sehested, Tomas Jernberg, Dan Atar, Borja Ibanez, Eva Prescott

Additional file 2. Overview of meta-analyses regarding beta-blocker therapy after myocardial infarction.

Funding

Novo Nordisk Fonden Hjerteforeningen

History

Usage metrics

Keywords

Myocardial infarction Beta-blocker treatment Long-term prognosis Randomized controlled trial

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 2 of Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial

Funding

Novo Nordisk Fonden Hjerteforeningen

History

Usage metrics

Categories

Keywords

Licence

Exports